Retinoids, which are commonly used to combat acne, have several side effects, including the development of inflammatory bowel disease (IBD). To investigate the effect of retinoids on the gastrointestinal system in vivo, Oehlers et al. developed a model of IBD by immersing zebrafish larvae in dextran sodium sulfate (DSS), a chemical commonly used to induce colitis in rodents. As occurs in individuals with IBD, DSS exposure induced a protective mucosecretory response in zebrafish larvae. Both endogenous and DSS-induced mucus secretion were suppressed by exogenous retinoic acid, which promoted inflammation and exacerbated enterocolitis. These findings introduce a new model of IBD and provide evidence for how the disease might be triggered in patients treated with retinoids. Page 457
Retinoids exacerbate IBD in a new zebrafish model Open Access
Retinoids exacerbate IBD in a new zebrafish model. Dis Model Mech 1 July 2012; 5 (4): 414. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
A new perspective on disease research
DMM publishes perspectives - peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Other journals from
The Company of Biologists